
ILIAS Biologics Publishes Groundbreaking Study on Exosome Therapy for Chorioamnionitis in Non-human Primates
Advancing Exosome Technology to Address Inflammatory Conditions in Women's Health SEOUL, EUNPYEONG, SOUTH KOREA, July 9, 2025 /EINPresswire.com/ -- ILIAS Biologics (CEO Dr. Chulhee Choi, hereinafter "ILIAS"), a leading biotech …